|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2000-5-12
|
|
pubmed:abstractText |
The effect of sex hormone replacement therapy on lipoprotein metabolism is thought to be less marked with the transdermal route because of the lack of hepatic first-pass effect. The aim of this study was to evaluate the effects of testosterone replacement therapy given transdermally via a permeation-enhanced system on plasma lipolytic enzymes (hepatic and lipoprotein lipase), LDL and HDL subfraction concentrations.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0300-0664
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
765-9
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10619982-Administration, Cutaneous,
pubmed-meshheading:10619982-Adult,
pubmed-meshheading:10619982-Dihydrotestosterone,
pubmed-meshheading:10619982-Hormone Replacement Therapy,
pubmed-meshheading:10619982-Humans,
pubmed-meshheading:10619982-Hypogonadism,
pubmed-meshheading:10619982-Lipase,
pubmed-meshheading:10619982-Lipoproteins,
pubmed-meshheading:10619982-Lipoproteins, HDL,
pubmed-meshheading:10619982-Lipoproteins, LDL,
pubmed-meshheading:10619982-Liver,
pubmed-meshheading:10619982-Longitudinal Studies,
pubmed-meshheading:10619982-Male,
pubmed-meshheading:10619982-Testosterone
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Alterations in hepatic lipase and lipoprotein subfractions with transdermal testosterone replacement therapy.
|
|
pubmed:affiliation |
Department of Medicine, University of Hong Kong, Hong Kong.
|
|
pubmed:publicationType |
Journal Article
|
